Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M498Revenue $M25.1Net Margin (%)-1,069.4Z-Score-9.0
Enterprise Value $M715EPS $-1.4Operating Margin %-893.9F-Score2
P/E(ttm))0Cash Flow Per Share $0.7Pre-tax Margin (%)-1,070.1Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.0Cash flow > EarningsY
Price/Sales19.55-y EBITDA Growth Rate %0Current Ratio1.0Lower Leverage y-yN
Price/Cash Flow6.3y-y EBITDA Growth Rate %0ROA % (ttm)-62.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M195ROI % (ttm)-57.3Gross Margin Increase y-yN

Gurus Latest Trades with EXEL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXELJean-Marie Eveillard 2014-03-31 Reduce-0.01%$3.38 - $8.24
($6.84)
$ 2.54-169%Reduce -65.91%400,000
EXELJohn Burbank 2013-03-31 Sold Out -0.0019%$4.41 - $5.03
($4.69)
$ 2.54-85%Sold Out0
EXELJean-Marie Eveillard 2012-09-30 Add0.02%$4.28 - $6.45
($5.29)
$ 2.54-108%Add 422.58%1,175,800
EXELCarl Icahn 2011-09-30 Sold Out -0.43%$5.5 - $9.22
($7.34)
$ 2.54-189%Sold Out0
EXELJean-Marie Eveillard 2010-12-31 Buy 0.01%$3.98 - $9.08
($5.66)
$ 2.54-123%New holding280,000
EXELJean-Marie Eveillard 2009-12-31 Sold Out -0.02%$5.33 - $8
($6.86)
$ 2.54-170%Sold Out0
EXELJean-Marie Eveillard 2009-09-30 Buy 0.02%$4.4 - $6.99
($5.65)
$ 2.54-122%New holding274,700
EXELJean-Marie Eveillard 2009-06-30 Sold Out -0.01%$4.16 - $5.55
($4.88)
$ 2.54-92%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXEL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


EXEL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARCHESI VINCENT TDirector 2014-09-17Buy20,000$1.7148.54view
WILLSEY LANCEDirector 2013-08-29Buy10,000$5.15-50.68view
MARCHESI VINCENT TDirector 2012-12-20Buy4,000$4.68-45.73view
MARCHESI VINCENT TDirector 2012-12-19Buy6,000$4.72-46.19view
Schwab GiselaEVP and Chief Medical Officer 2012-12-10Buy25,000$4.39-42.14view
MARCHESI VINCENT TDirector 2012-06-14Sell7,000$5.13-50.49view
RIVERA LUPE MEVP, Operations 2010-12-17Sell29,427$8.5-70.12view
RIVERA LUPE MEVP, Operations 2010-12-15Sell75,000$7.5-66.13view
Schwab GiselaEVP & Chief Medical Officer 2010-12-09Sell4,112$6.5-60.92view
WILLSEY LANCEDirector 2010-09-07Buy36,200$3.6-29.44view

Press Releases about EXEL :

    Quarterly/Annual Reports about EXEL:

    News about EXEL:

    Articles On GuruFocus.com
    5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
    5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc. Sep 28 2014 
    Weekly 3-Year Low Highlights: UAN, CLD, EXEL, QNST Sep 07 2014 
    Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian Trust, Millennial Media Inc., Exelix May 05 2014 
    5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
    Exelixis Inc. Reports Operating Results (10-K) Feb 22 2011 
    Exelixis Inc. (EXEL) CFO Frank Karbe buys 16,500 Shares Aug 26 2010 
    Exelixis Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Exelixis Inc. Reports Operating Results (10-Q) May 11 2010 
    Exelixis Announces Second Quarter 2009 Financial Results Jul 30 2009 

    More From Other Websites
    Biotech in nice uptrend: Adami Mar 25 2015
    Is Exelixis (EXEL) Stock a Solid Choice Right Now? - Tale of the Tape Mar 18 2015
    GSK's big bet: Tapping our body's electronics Mar 11 2015
    18 Biotech Stocks These Wall Street Analysts Are Tracking Mar 11 2015
    EXELIXIS, INC. Files SEC form 8-K, Other Events Mar 09 2015
    Exelixis to Present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3 Mar 06 2015
    Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update Mar 06 2015
    Is Exelixis Under-the-Radar Growth? Mar 06 2015
    Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape Feb 27 2015
    Exelixis to Present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3 Feb 26 2015
    Exelixis reports 4Q loss Feb 24 2015
    Exelixis reports 4Q loss Feb 24 2015
    Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update Feb 24 2015
    Q4 2014 Exelixis Inc Earnings Release - After Market Close Feb 24 2015
    Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog Feb 23 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Wal-Mart, Priceline, Ocera Therapeutics, Netlist Feb 19 2015
    Ahead of the Bell: Exelixis shares climb, FDA to review drug Feb 19 2015
    Ahead of the Bell: Exelixis shares climb, FDA to review drug Feb 19 2015
    Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with... Feb 19 2015
    Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with... Feb 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK